Total Payments
$2,273
2024 Payments
$519.49
Companies
13
Transactions
152
Payment Breakdown by Category
Food & Beverage$2,259 (99.4%)
Education$13.92 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,259 | 151 | 99.4% |
| Education | $13.92 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $418.30 | 51 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $278.75 | 20 | $0 (2024) |
| Lundbeck LLC | $272.65 | 15 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $215.02 | 6 | $0 (2024) |
| Alkermes, Inc. | $203.82 | 12 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $200.78 | 10 | $0 (2023) |
| IRONSHORE PHARMACEUTICALS INC. | $180.36 | 10 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $149.85 | 9 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $123.88 | 8 | $0 (2024) |
| ITI, Inc. | $84.22 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $519.49 | 28 | Lundbeck LLC ($194.93) |
| 2023 | $797.24 | 59 | ABBVIE INC. ($228.97) |
| 2022 | $399.57 | 33 | ABBVIE INC. ($145.48) |
| 2021 | $556.60 | 32 | Otsuka America Pharmaceutical, Inc. ($163.90) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 2 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: CNS | ||||||
| 01/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.19 | General |
| Category: PSYCHIATRY | ||||||
| 01/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Central Nervous System | ||||||
| 12/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.26 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $21.71 | General |
| Category: PSYCHOLOGY | ||||||
| 12/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $21.96 | General |
| Category: PSYCHOLOGY | ||||||
| 12/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: CNS | ||||||
| 10/23/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.31 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $20.96 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: CNS | ||||||
| 09/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $27.32 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/28/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $13.12 | General |
| Category: PSYCHOLOGY | ||||||
| 08/22/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: PSYCHIATRY | ||||||
About Debra Stone, MSN, LCSW
Debra Stone, MSN, LCSW is a Clinical healthcare provider based in Claremore, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457463754.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Debra Stone, MSN, LCSW has received a total of $2,273 in payments from pharmaceutical and medical device companies, with $519.49 received in 2024. These payments were reported across 152 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,259).
Ad
Practice Information
- Specialty Clinical
- Other Specialties Student in an Organized Health Care Education/Training Program, Clinical Nurse Specialist
- Location Claremore, OK
- Active Since 08/31/2006
- Last Updated 08/30/2011
- Taxonomy Code 1041C0700X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457463754
Products in Payments
- REXULTI (Drug) $509.99
- VRAYLAR (Drug) $418.30
- HETLIOZ (Drug) $200.78
- ARISTADA (Drug) $187.55
- JORNAY PM (Drug) $180.36
- AUSTEDO (Drug) $152.72
- TRINTELLIX (Drug) $123.88
- CAPLYTA (Drug) $104.88
- Qelbree (Drug) $78.42
- Azstarys (Drug) $75.88
- QELBREE (Drug) $71.43
- Austedo XR (Drug) $62.30
- Auvelity (Drug) $48.73
- ABILIFY MAINTENA (Drug) $28.78
- LYBALVI (Drug) $16.27
- BRINTELLIX (Drug) $12.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.